Aptamer-Modified Magnetic Nanoparticles as Targeted Drug Delivery Systems for Hepatocellular Carcinoma

<b>Background</b>: Hepatocellular carcinoma is associated with high mortality and increasing incidence. Sorafenib, a cornerstone of therapy for advanced hepatocellular carcinoma, presents certain disadvantages, including low bioavailability and poor water solubility. This work describes a new strate...

Descripción completa

Detalles Bibliográficos

Autores principales:	Alexandra Pusta, Mihaela Tertis, Bianca Ciocan, Rodica Turcu, Izabell Crăciunescu, Victor C. Diculescu, George E. Stan, Stefan Bulat, Alina Porfire, Andreea-Elena Petru, Ionel Fizeșan, Simona Mirel, Cecilia Cristea
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2025-10-01
Colección:	Pharmaceutics
Materias:	aptamers magnetic nanoparticles sorafenib hepatocellular carcinoma targeted drug delivery
Acceso en línea:	https://www.mdpi.com/1999-4923/17/10/1292
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!